Jaźwiec B - Search Results

1

[Serum soluble tumor necrosis factor alpha receptor (s-TNF-alpha R) and acute phase proteins as factors of a disease activity (and also as prognostic factors?) in patients with malignant lymphomas].

Kapelko-Słowik K, Urbaniak-Kujda D, Jaźwiec B, Tomaszewska-Toporska B, Kuliczkowski K. Kapelko-Słowik K, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2001 Apr;105(4):285-9. Pol Arch Med Wewn. 2001. PMID: 11761799 Polish.

2

Recovery of natural cytotoxicity after bone marrow transplantation.

Lange A, Jazwiec B, Tomaszewska-Toporska B, Toporski J. Lange A, et al. Among authors: jazwiec b. Immunol Invest. 1991 Apr;20(2):207-13. doi: 10.3109/08820139109050789. Immunol Invest. 1991. PMID: 1830864

3

[Cytogenetic changes in Ph(+) chronic granulocytic leukemia under the influence of interferon alpha (IFN-alpha) therapy].

Haus O, Kotlarek-Haus S, Makowska I, Duszeńko E, Jaźwiec B, Kuliczkowski K. Haus O, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2000 Jan-Feb;103(1-2):15-22. Pol Arch Med Wewn. 2000. PMID: 11236254 Polish.

4

[Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ].

Kapelko-Słowik K, Wołowiec D, Sedek K, Jaźwiec B, Urbaniak-Kujda D, Kuliczkowski K. Kapelko-Słowik K, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2002 Sep;108(3):849-53. Pol Arch Med Wewn. 2002. PMID: 12600181 Polish.

5

[Expression of Fas receptor and soluble Fas ligand (sFasL) concentration in acute leukemia].

Urbaniak-Kujda D, Jaźwiec B, Tomaszewska-Toporska B, Wołowiec D, Kapelko-Słowik K, Kuliczkowski K. Urbaniak-Kujda D, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2002 Sep;108(3):873-8. Pol Arch Med Wewn. 2002. PMID: 12600184 Polish.

6

[Cytogenetic changes and their prognostic significance in elderly acute myeloid leukemia].

Haus O, Kotlarek-Haus S, Duszeńko E, Makowska I, Potoczek S, Nowak E, Jaźwiec B, Kuliczkowski K. Haus O, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2003 Jun;109(6):571-7. Pol Arch Med Wewn. 2003. PMID: 14567089 Polish.

7

Interleukin-17 in acute myeloid leukemia.

Wróbel T, Mazur G, Jazwiec B, Kuliczkowski K. Wróbel T, et al. Among authors: jazwiec b. J Cell Mol Med. 2003 Oct-Dec;7(4):472-4. doi: 10.1111/j.1582-4934.2003.tb00250.x. J Cell Mol Med. 2003. PMID: 14754516 Free PMC article.

8

[Plasma concentration of the shed form of L-selectin (sL-selectin) in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) and its relation to the clinical course].

Kapelko-Slowik K, Jaźwiec B, Mirosław S, Wołowiec D, Urbaniak-Kujda D, Tomaszewska-Toporska B, Potoczek S, Ciszak L, Kuliczkowski K. Kapelko-Slowik K, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2004 Nov;112(5):1283-8. Pol Arch Med Wewn. 2004. PMID: 15773509 Polish.

9

[Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].

Poreba M, Jaźwiec B, Kuliczkowski K, Poreba R. Poreba M, et al. Among authors: jazwiec b. Pol Arch Med Wewn. 2005 Jan;113(1):27-34. Pol Arch Med Wewn. 2005. PMID: 16130598 Polish.

10

sVE-cadherin and sCD146 serum levels in patients with multiple myeloma.

Wrobel T, Mazur G, Wolowiec D, Jazwiec B, Sowinska E, Kuliczkowski K. Wrobel T, et al. Among authors: jazwiec b. Clin Lab Haematol. 2006 Feb;28(1):36-9. doi: 10.1111/j.1365-2257.2006.00756.x. Clin Lab Haematol. 2006. PMID: 16430458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters